Molecular targeted therapy for anticancer treatmentHye‐Young Min, Ho‐Young Lee|Experimental & Molecular Medicine|2022Cited by 495
Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of ErlotinibFloriana Morgillo, Ho‐Young Lee|Cancer Research|2006Cited by 336
Effects of Deguelin on the Phosphatidylinositol 3-Kinase/Akt Pathway and Apoptosis in Premalignant Human Bronchial Epithelial CellsKyung‐Hee Chun, Ho‐Young Lee, Jerome W. Kosmeder et al.|JNCI Journal of the National Cancer Institute|2003Cited by 257
Design, Synthesis, and Biological Evaluation of Novel Deguelin-Based Heat Shock Protein 90 (HSP90) Inhibitors Targeting Proliferation and AngiogenesisDong-Jo Chang, Young‐Ger Suh, Young Taek Han et al.|Journal of Medicinal Chemistry|2012Cited by 102
Hypoxia-inducible Factor 1α and Antiangiogenic Activity of Farnesyltransferase Inhibitor SCH66336 in Human Aerodigestive Tract CancerJi‐Youn Han, Ho‐Young Lee|JNCI Journal of the National Cancer Institute|2005Cited by 97